It is learned from many sources that Beiden Medical has completed a new round of billion-yuan financing by the end of 2017. The investment of the old shareholder “Oriental Fuhai†also participated in the investment. Beiden Medical is a medical device B2B platform. In November 2016, it won a round of financing of RMB 65 million. The investors include Zhongwei Fund, Oriental Fuhai and Puhua Capital. In June 2015, Beiden Medical received a 30 million yuan Pre-A round of financing for sharing investment and Shenzhen Pengrui Investment Group Co., Ltd.; previously, Beiden Medical also received an angel investment from Jingkui Capital.
Beideng Medical was established in 2012. The platform is mainly purchased from upstream medical device manufacturers, serving downstream small and medium-sized medical device distributors and some private medical institutions. Founder Ding Haibo and several partners have previously worked for Alibaba and Global. The B2B department of the resources, the team members are also from professional medical equipment production suppliers such as Mindray and Olympus.
Beideng Medical has docked 500 upstream medical device manufacturers, nearly 15,000 small and medium-sized dealers, and there are 20,000 SKUs in the platform. The platform has established two online and offline sales systems. In 2017, Beiden Medical has been working hard. In order to promote localization operations, complete multi-point layout online.
Yiou has reported that medical equipment B2B company joint medical doctors, the entire market has a channel of pain points, public hospitals have great troubles in procurement, the purchasers mostly through the bidding method to obtain the supply side, the majority of hospitals and local distributors to maintain long-term Cooperation, it is difficult for hospitals to choose more manufacturers, and procurement channels are limited.
For manufacturers, it is very difficult to sell a large area of ​​direct sales. Most dealers rely on local customer relationships. Manufacturers need to find a large number of distributors across the country. Only a small number of large medical device brands in the industry can be established nationwide. Sales channels.
For small and micro agents, they cannot provide professional service capabilities after entering local areas, and they lack sufficient voice right in the upstream. Beiden Medical provides product supply, supply chain finance and after-sales to the upper and lower ends of the market through the platform model. Services, information technology and other support to achieve links between the upper and lower ends, to promote industrial upgrading.
From the perspective of investment, medical devices are booming in overseas markets. According to the latest report of CB Insights in the United States, the amount of investment and financing transactions of private medical device companies in the world has increased significantly in 2016, and 479 investment projects have been completed. $4.8 billion. In the global medical device investment and financing transaction, the United States accounted for 77% of the trading share, followed by Israel and the United Kingdom.
The global pharmaceutical and medical device consumption ratio is about 1:0.7, while the developed countries such as Europe, the United States and Japan have reached 1:1.02. The global medical device market has occupied 42% of the total size of the international pharmaceutical market, and has expanded. The market has the characteristics of large prospects, rapid growth, and obvious pain points in the industry. China does not have a listed company in the field of equipment circulation.
SHAANXI HAIBO BIOTECHNOLOGY CO., LTD , https://www.rozenbio.com